A Study to Evaluate Safety and PK Profiles of OLX10010 in Healthy Subjects
Clinical trial NCT03569267 · COMPLETED
Trial details
- NCT number
- NCT03569267
- Sponsor
- Olix Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-21
- Primary completion
- 2019-06-27
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.